Results 21 to 30 of about 140,776 (178)

Impact of treatment with dimethyl fumarate on sleep quality in patients with relapsing-remitting multiple sclerosis: A multicentre Italian wearable tracker study

open access: yesMultiple Sclerosis Journal - Experimental, Translational and Clinical, 2023
Background Sleep disorders are common in patients with multiple sclerosis and have a bidirectional interplay with fatigue and depression. Objective To evaluate the effect of treatment with oral dimethyl fumarate on the quality of sleep in relapsing ...
Giancarlo Comi   +14 more
doaj   +1 more source

Dimethyl fumarate attenuates pain behaviors in osteoarthritis rats induction of Nrf2-mediated mitochondrial biogenesis

open access: yesMolecular Pain, 2022
Osteoarthritis (OA), a chronic degenerative disease, leads to pain and loss of function. Existing treatments for OA pain have limited efficacy and show significant side effects.
Shao-Jie Gao   +8 more
doaj   +1 more source

Sleep-related breathing disorder (central sleep apnoea) improved coincidentally by medical therapy with fumarates (dimethyl fumarate)

open access: yes, 2023
Central sleep apnoea (CSA) is a sleep disorder characterized by the repeated cessation or reduction of both airflow and ventilatory effort when sleeping.
Abdulmajeed M Albadi   +2 more
core   +1 more source

Dimethyl Fumarate Used as an Effective Treatment for Granuloma Annulare Disseminatum: An Immunohistochemical Case Study [PDF]

open access: yes, 2023
This investigation demonstrates the use of dimethyl fumarate (DMF) for the treatment of disseminated granuloma annulare (GAD), a rare and chronic inflammatory skin disease.
Simon Bossart   +13 more
core   +2 more sources

Overall and patient-level comparative effectiveness of dimethyl fumarate and fingolimod: A precision medicine application to the Observatoire Français de la Sclérose en Plaques registry

open access: yesMultiple Sclerosis Journal - Experimental, Translational and Clinical, 2022
Background Comparing real-world effectiveness and tolerability of therapies for relapsing-remitting multiple sclerosis is increasingly important, though average treatment effects fail to capture possible treatment effect heterogeneity.
Gabrielle Simoneau   +10 more
doaj   +1 more source

Dimethyl fumarate confers neuroprotection by casein kinase 2 phosphorylation of Nrf2 in murine intracerebral hemorrhage

open access: yesNeurobiology of Disease, 2015
Background and purpose: Edema formation, inflammation and increased blood–brain barrier permeability contribute to poor outcomes after intracerebral hemorrhage (ICH).
Loretta O. Iniaghe   +5 more
doaj   +1 more source

Safety and persistence of dimethyl fumarate as a treatment for relapsing-remitting multiple-sclerosis [PDF]

open access: yesFarmacia Hospitalaria, 2021
Objective: Dimethyl fumarate is a medication approved for the treatment of relapsing-remitting multiple sclerosis. The purpose of the study was to evaluate the safety and persistence of dimethyl fumarate in clinical practice and analyze the ...
Silvia Boullosa-Lale   +3 more
doaj   +1 more source

The Role of Glutathione-S Transferase in Psoriasis and Associated Comorbidities and the Effect of Dimethyl Fumarate in This Pathway

open access: yesFrontiers in Medicine, 2022
Psoriasis vulgaris is a chronic inflammatory skin disease characterized by well-demarcated scaly plaques. Oxidative stress plays a crucial role in the psoriasis pathogenesis and is associated with the disease severity.
Elena Campione   +16 more
doaj   +1 more source

Efficacy and safety of dimethyl fumarate in treatment-naïve Japanese patients with multiple sclerosis: Interim analysis of the randomized placebo-controlled study

open access: yesMultiple Sclerosis Journal - Experimental, Translational and Clinical, 2019
Background The use of dimethyl fumarate has not been reported in treatment-naïve Japanese patients with relapsing–remitting multiple sclerosis. Objectives The purpose of this study was to evaluate the efficacy and safety of dimethyl fumarate in treatment-
Masahiro Mori   +7 more
doaj   +1 more source

DNA methylation changes in CD4 T cells isolated from multiple sclerosis patients on dimethyl fumarate

open access: yesMultiple Sclerosis Journal - Experimental, Translational and Clinical, 2018
Background Dimethyl fumarate is an oral treatment for multiple sclerosis, whose mechanism of action is not fully understood. Objective To investigate the effects of dimethyl fumarate on DNA methylation in the CD4 + T cells of multiple sclerosis patients.
Vicki E Maltby   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy